1. A New Model to Study the Role of Arachidonic Acid in Colon Cancer Pathophysiology
- Author
-
Logan Vincent, Jennifer S. Goldsby, Jennifer M. Monk, Yang Yi Fan, Robert S. Chapkin, Evelyn S. Callaway, and Peiying Yang
- Subjects
Fatty Acid Desaturases ,0301 basic medicine ,Cancer Research ,medicine.medical_specialty ,Colorectal cancer ,Biology ,Article ,Metastasis ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Animals ,Mice, Knockout ,Arachidonic Acid ,Azoxymethane ,Cancer ,medicine.disease ,Disease Models, Animal ,030104 developmental biology ,Endocrinology ,Oncology ,chemistry ,Eicosanoid ,030220 oncology & carcinogenesis ,Colonic Neoplasms ,Knockout mouse ,Immunology ,Arachidonic acid ,Aberrant crypt foci - Abstract
A significant increase in cyclooxygenase 2 (COX2) gene expression has been shown to promote cylcooxygenase-dependent colon cancer development. Controversy associated with the role of COX2 inhibitors indicates that additional work is needed to elucidate the effects of arachidonic acid (AA)-derived (cyclooxygenase and lipoxygenase) eicosanoids in cancer initiation, progression, and metastasis. We have recently developed a novel Fads1 knockout mouse model that allows for the investigation of AA-dependent eicosanoid deficiency without the complication of essential fatty acid deficiency. Interestingly, the survival rate of Fads1-null mice is severely compromised after 2 months on a semi-purified AA-free diet, which precludes long-term chemoprevention studies. Therefore, in this study, dietary AA levels were titrated to determine the minimal level required for survival, while maintaining a distinct AA-deficient phenotype. Null mice supplemented with AA (0.1%, 0.4%, 0.6%, 2.0%, w/w) in the diet exhibited a dose-dependent increase (P < 0.05) in AA, PGE2, 6-keto PGF1α, TXB2, and EdU-positive proliferative cells in the colon. In subsequent experiments, null mice supplemented with 0.6% AA diet were injected with a colon-specific carcinogen (azoxymethane) in order to assess cancer susceptibility. Null mice exhibited significantly (P < 0.05) reduced levels/multiplicity of aberrant crypt foci (ACF) as compared with wild-type sibling littermate control mice. These data indicate that (i) basal/minimal dietary AA supplementation (0.6%) expands the utility of the Fads1-null mouse model for long-term cancer prevention studies and (ii) that AA content in the colonic epithelium modulates colon cancer risk. Cancer Prev Res; 9(9); 750–7. ©2016 AACR.
- Published
- 2016
- Full Text
- View/download PDF